REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
3 hedge funds and large institutions have $3.15M invested in REVIVA PHARMA HLDGS INC in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 11 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
38.89% less ownership
Funds ownership: 42.79% → 3.9% (-39%)
77% less funds holding
Funds holding: 13 → 3 (-10)
91% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 11
91% less capital invested
Capital invested by funds: $35.4M → $3.15M (-$32.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.63M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$8.78M |
| 2 |
GCL
Glazer Capital LLC
New York
|
-$7.63M |
| 3 |
MSU
Mizuho Securities USA
New York
|
-$5.17M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$3.17M |
| 5 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$2.6M |
RVPH Hedge Fund Activity: Q4 2020 in Review
3 of the 5,677 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q4 2020, worth a combined $3.15M — down 91% from $35.4M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of RVPH and 1 opened new positions — a net loss of 10 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $3.63M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $8.78M sold.
- 3 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q4 2020, down from 13 in Q3 2020.
- Funds reported $3.15M of REVIVA PHARMA HLDGS INC stock for Q4 2020, down 91% quarter-over-quarter.
- 1 fund opened new REVIVA PHARMA HLDGS INC positions in Q4 2020 and 11 closed out, a net change of -10 holders.
- The largest REVIVA PHARMA HLDGS INC buyer in Q4 2020 was Sabby Management, an estimated $3.63M added.
- The largest REVIVA PHARMA HLDGS INC seller in Q4 2020 was Hudson Bay Capital Management, an estimated $8.78M sold.
Based on aggregated 13F filings for Q4 2020.